Adverse Mucocutaneous Reaction to Pertuzumab in a Patient with HER2-Positive Metastatic Breast Cancer

被引：2
|
作者：
Kowalczyk, Lidia [1 ]
Singer, Christian F. [2 ]
Staudigl, Christine [2 ]
Weber, Myriam [2 ]
Farr, Alex [2 ]
机构：
[1] Univ Vet Med, Clin Unit Anesthesiol & Perioperat Intens Care Me, Vienna, Austria
[2] Med Univ Vienna, Dept Obstet & Gynecol, Ctr Breast Hlth, Waehringer Guertel 18-20, A-1090 Vienna, Austria
来源：
BREAST JOURNAL | 2017年 / 23卷 / 03期
关键词：
D O I：
10.1111/tbj.12676
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352 / 353
页数：2
相关论文
共 50 条
  • [1] Pertuzumab (Perjeta) for HER2-Positive Metastatic Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1395): : 59 - 60
  • [2] Pertuzumab biosimilar in HER2-positive metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2025, 85 (01) : 21 - 21
  • [3] Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
    Swain, Sandra M.
    Baselga, Jose
    Kim, Sung-Bae
    Ro, Jungsil
    Semiglazov, Vladimir
    Campone, Mario
    Ciruelos, Eva
    Ferrero, Jean-Marc
    Schneeweiss, Andreas
    Heeson, Sarah
    Clark, Emma
    Ross, Graham
    Benyunes, Mark C.
    Cortes, Javier
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (08): : 724 - 734
  • [4] Use of Pertuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer
    Leticia De Mattos-Arruda
    Javier Cortes
    Advances in Therapy, 2013, 30 : 645 - 658
  • [5] Use of Pertuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer
    De Mattos-Arruda, Leticia
    Cortes, Javier
    ADVANCES IN THERAPY, 2013, 30 (07) : 645 - 658
  • [6] Pertuzumab in HER2-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1709 - 1716
  • [7] Pertuzumab: A New Targeted Therapy for HER2-Positive Metastatic Breast Cancer
    Malenfant, Stephanie J.
    Eckmann, Karen R.
    Barnett, Chad M.
    PHARMACOTHERAPY, 2014, 34 (01): : 60 - 71
  • [8] Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Hirakawa, Kosei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 17 - 26
  • [9] PERTUZUMAB FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE METASTATIC BREAST CANCER
    Smith, M. B.
    Reardon, J.
    Olson, E. M.
    DRUGS OF TODAY, 2012, 48 (11) : 713 - 722
  • [10] Pertuzumab In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
    Keating, Gillian M.
    DRUGS, 2012, 72 (03) : 353 - 360
12345